What Is the Visian ICL?
The Visian ICL is a phakic intraocular lens (IOL) used during Refractive Surgery for correcting myopia (nearsightedness). Unlike IOLs, which are used during cataract surgery, the Visian ICL does not replace the eye’s natural lens. Instead, the ICL is placed between the iris and the natural lens to allow the ICL lens to work with your natural optical system and allow light to better focus on the retina. Because the phakic IOL does not replace the lens, but supplements it like a prescription contact lens on the surface of the eye, it is sometimes referred to as an implantable contact lens.
The Visian ICL offers another option for treating myopia. Now, patients who are seeking the latest approved procedures for vision correction, or who want to avoid the permanence of laser vision correction, have another choice for correcting their nearsightedness.
TESTIMONIAL: I had Visian ICL surgery on May 1st 2014 and it was the one of the best decisions of my life. After being dependent on glasses or contacts for 24 years it has been so wonderful waking up and being able to see! I enjoy travelling and living an active lifestyle all that has been made better not having to rely on contacts and glasses to see! Dr. Nedrud is an amazing surgeon and the whole experience at Rocky Mountain Lasik was wonderful!!
What Makes the Visian ICL Different?
Although the Visian ICL is often informally named an “implantable contact lens”, in the United States, the acronym ICL in the Visian ICL stands for “Implantable Collamer Lens”. Collamer is the unique material that the lens is made of.
Quality of Vision
The Visian ICL offers unparalleled quality of vision, providing excellent contrast. Two unique factors help explain this superior optical performance. First, the Visian ICL is made of Collamer – a soft, flexible lens material that contains a small amount of collagen – making the lens extremely biocompatible for a lifetime of clear vision. Second, the lens is placed inside the eye, where it continues to focus light accurately without any maintenance required.
Safe, Proven Procedure
The safety and effectiveness of the Visian ICL implantation procedure has been proven with over 125,000 implants worldwide as well as recent U.S. FDA approval. Unlike corneal refractive surgery, the Visian ICL does not permanently alter the structure of the eye. Instead, the phakic IOL is placed in the eye’s posterior chamber, where it works with the natural lens to correct vision.
Unlike other phakic IOLs, the Visian ICL is foldable. This feature allows physicians to implant the lens using a smaller incision. The small incision procedure is a technique that is familiar to eye surgeons. The Visian ICL requires a 2.8mm to 3.0mm incision as opposed to the 6.0mm incision required by other FDA-approved phakic IOLs. This smaller incision is seen as less invasive, does not require sutures, and is astigmatically neutral.
Removable, if Necessary
Although the Visian ICL is meant to stay in the eye indefinitely, it is easily removed by a trained ophthalmic surgeon, leaving the patient’s future options open.
The Visian ICL features UV eye protection, assisting in the prevention of the development of various eye disorders. UV radiation may contribute to the development of macular degeneration, the leading cause of vision loss among older Americans; and cataracts, a major cause of visual impairment and blindness around the world.
A shorter alternative:
What are the advantages of the Visian ICL?
There are many unique advantages to the Visian ICL, including:
1. Performance – provides excellent quality of vision with predictable and stable results.
2. Simplicity – Inserted through a micro-incision utilizing a procedure that is familiar to the surgeon. The lens is invisible to both you and observers. It requires no maintenance.
3. Versatility – Capable of correcting a wide range of nearsightedness, and is removable if necessary.
4. Biocompatibility – Collamer, an exceptional lens material offering unparalleled biocompatibility.
5. Safety – Safe, proven procedure that is familiar to ophthalmologists.